Effect of the ETB receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 1120-1122

  Rai, Aarati ^a   Rajeshkumar, N V ^a   Gulati, Anil ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Drug delivery; ETB receptor agonist; IRL 1620; Paclitaxel; Pharmacokinetics

Indexed keywords

ENDOTHELIN B RECEPTOR ANTAGONIST; PACLITAXEL; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; BREAST TUMOR; COMPUTER PROGRAM; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; NONHUMAN; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ENDOTHELINS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; PACLITAXEL; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B;

EID: 33744899835     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Bagnato A, Natali PG. Endothelin receptors as novel targets in tumor therapy. J Transl Med 2:16, 2004.
2. Bagnato A, Natali PG. Targeting endothelin axis in cancer. Cancer Treat Res 119:293-314, 2004.
3. Wulfing P, Diallo R, Kersting C, Wulfing C, Poremba C, Rody A, Greb RR, Bocker W, Kiesel L. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin Cancer Res 9:4125-4131, 2003.
4. Wulfing P, Diallo R, Kersting C, Wulfing C, Poremba C, Greb RR, Bocker W, Kiesel L. Endothelin-1, endothelin-A- and endothelin-B-receptor expression in preinvasive and invasive breast disease. Oncol Rep 11:791-796, 2004.
5. Rai A, Gulati A. Evidence for the involvement of ET(B) receptors in ET-1-induced changes in blood flow to the rat breast tumor. Cancer Chemother Pharmacol 51:21-28, 2003.
6. Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K, Urade Y, Inui T, Yamamura T, Okada T. A potent and specific agonist, Suc-[Glu9,Ala11,15]- endothelin-1(8-21), IRL-1620, for the ETB receptor. Biochem Biophys Res Commun 184:953-959, 1992.
7. Rajeshkumar NV, Rai A, Gulati A. Endothelin B receptor agonist, IRL-1620, enhances the antitumor efficacy of paclitaxel in breast tumor rats. Breast Cancer Res Treat 94:237-247, 2005.
8. Rowinsky EK, Wright M, Monsarrat B, Lesser GJ, Donehower RC. Taxol: pharmacology, metabolism and clinical implications. Cancer Surv 17:283-304, 1993.
9. Mehta RG. Experimental basis for the prevention of breast cancer. Eur J Cancer 36:1275-1282, 2000.
10. Lhuillery C, Bougnoux P, Groscolas R, Durand G. Time-course study of adipose tissue fatty acid composition during mammary tumor growth in rats with controlled fat intake. Nutr Cancer 24:299-309, 1995.
11. Buehler PW, Haney CR, Gulati A, Ma L, Hsia CJ. Polynitroxyl hemoglobin: a pharmacokinetic study of covalently bound nitroxides to hemoglobin platforms. Free Radic Biol Med 37:124-135, 2004.
12. Rubin SA, Levin ER. Clinical review 53: the endocrinology of vasoactive peptides: synthesis to function. J Clin Endocrinol Metab 78: 6-10, 1994.
13. Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 4:423-436, 2004.
14. Blagosklonny MV. Antiangiogenic therapy and tumor progression. Cancer Cell 5:13-17, 2004.
15. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342, 2004.
16. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027, 2005.
17. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58-62, 2005.
18. Gulati A, Rai A, Rajeshkumar NV. ET B receptor agonist, IRL-1620, enhances the efficacy of paclitaxel in reducing breast tumor volumes in rats (abstract 1443). In: Program of the 96th AACR annual meeting, Anaheim, CA; p338, 2005.
19. Rajeshkumar NV, Rai A, Green A, Gionetti G, Das Gupta TK, Gulati A. Endothelin B receptor agonist, IRL-1620, increases blood perfusion and enhances paclitaxel delivery to tumor (abstract 5741). In: Program of the 96th AACR annual meeting, Anaheim, CA; p1349, 2005.